Funding supports development of first-in-class pan-ROCK inhibitor ROC-101 through Phase 2a clinical testing
The inspection concluded with zero form 483 observations
Encouraging early detection and breaking the silence around men’s health
Advent acquired Zentiva from Sanofi in 2018 and transformed the company into a highly successful standalone business
Nu Nutridac is a nutritional replenisher for neurodegenerative and anxiety-related disorders
AHLL will become a 100% subsidiary of AHEL with 99.42% held by AHEL and balance in the ESOP pool
Subscribe To Our Newsletter & Stay Updated